NPS Pharmaceuticals and Takeda Revise Agreements and NPS Re-Gains Full Worldwide Rights to Teduglutide and Recombinant Human Parathyroid Hormone 1-84

[Business Wire] – BEDMINSTER, N.J. & OSAKA, Japan–(BUSINESSWIRE)– NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) and Takeda Pharmaceutical Company Limited (TSE: 4502, “Takeda”) announced today that NPS has re-gained the full … more

View todays social media effects on NPSP

View the latest stocks trending across Twitter. Click to view dashboard

See who NPS is hiring next, click here to view